(Total Views: 569)
Posted On: 01/26/2022 10:27:25 AM
Post# of 154883
While we postulate - and wait - for the true reasons behind the change in leadership to emerge in the coming weeks, we have a big news event being formulated as we speak and write.
Yes, folks it's time the tournament of CytoDyn hit pieces, likely to be led by everyone's favorite short-bus driver, Mr. Adumb Fuhrerstein!
Welcome back my friends to the shit-show that never ends, we're so glad you could attend, step inside, step inside!
Down in the bowels of his meth lab, Mad Adumb is frantically hammering away at his keyboards, preparing HIS mis-interpretation of the events as only he can mis-interpret them. Let the short-bus shit-show begin!!
Tomorrow we may be reading headlines like these:
"What egregious act did the criminally-bent Pourhassen commit to force the once pro-Nader board to turn on him?"
Or ...
"Facing a mountain of debt, the CytoDyn BOD makes a cost-cutting move to cut their overpaid and underperforming CEO - but will this be enough to stave off a takeover from debtors? Is the John Fife Pharmaceutical Company the end-stage for CytoDyn?"
Or ...
"Shareholders giddy over perceived buyout dream is just that; a (Nader-inspired) dream (catcher) that is completely removed from reality. Who would buy this train-wreck of a underfunded company overburdened with debt and a string of clinical trial failures in its wake?"
Excitement returns to the CytoDyn stage and promises an exciting 2022 is on tap for shareholders, partners and patience for the patients. Let the fun begin!
Yes, folks it's time the tournament of CytoDyn hit pieces, likely to be led by everyone's favorite short-bus driver, Mr. Adumb Fuhrerstein!
Welcome back my friends to the shit-show that never ends, we're so glad you could attend, step inside, step inside!
Down in the bowels of his meth lab, Mad Adumb is frantically hammering away at his keyboards, preparing HIS mis-interpretation of the events as only he can mis-interpret them. Let the short-bus shit-show begin!!
Tomorrow we may be reading headlines like these:
"What egregious act did the criminally-bent Pourhassen commit to force the once pro-Nader board to turn on him?"
Or ...
"Facing a mountain of debt, the CytoDyn BOD makes a cost-cutting move to cut their overpaid and underperforming CEO - but will this be enough to stave off a takeover from debtors? Is the John Fife Pharmaceutical Company the end-stage for CytoDyn?"
Or ...
"Shareholders giddy over perceived buyout dream is just that; a (Nader-inspired) dream (catcher) that is completely removed from reality. Who would buy this train-wreck of a underfunded company overburdened with debt and a string of clinical trial failures in its wake?"
Excitement returns to the CytoDyn stage and promises an exciting 2022 is on tap for shareholders, partners and patience for the patients. Let the fun begin!
(2)
(0)
